Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy

Stacy Elliott
2007 Current Oncology  
Treatment with aromatase inhibitors for postmenopausal women with breast cancer has been shown to reduce or obviate invasive procedures such as hysteroscopy or curettage associated with tamoxifeninduced endometrial abnormalities. The side effect KEY WORDS Aromatase inhibitor therapy, breast cancer, gynecologic side effects, hormone therapy, sexual dysfunction, side effect management, side effect treatment
doi:10.3747/co.2007.151 fatcat:psj2ueiiivccnfp4imkw6ahvc4